Literature DB >> 3859414

CA 19-9 in the differential diagnosis between pancreatic cancer and chronic pancreatitis.

R Farini, C Fabris, P Bonvicini, A Piccoli, G del Favero, R Venturini, A Panucci, R Naccarato.   

Abstract

CA 19-9 serum concentration was determined by a immunoradiometric technique in 130 subjects to evaluate its role in differentiating pancreatic cancer from chronic pancreatitis. Two threshold values were chosen, 17 and 37 U/ml. With the former, sensitivity, specificity and diagnostic accuracy were 86.7, 62.3 and 49.0 respectively, with the latter 73.3, 87.0 and 60.3%. The receiver-operating characteristic curves demonstrated a satisfactory discriminating capacity of CA 19-9 as regards pancreatic cancer and chronic pancreatitis; in contrast, the discrimination was poor for other gastrointestinal diseases, mainly of a malignant nature.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3859414     DOI： 10.1016/0277-5379(85)90032-x

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN： 0277-5379


  12 in total

1.  Determination of tumor marker levels in cystic fluid of benign liver cysts.

Authors:  K Iwase; H Takenaka; S Oshima; A Yagura; Y Nishimura; K Yoshidome; T Tanaka
Journal:  Dig Dis Sci       Date:  1992-11       Impact factor: 3.199

Review 2.  Laboratory tests in the diagnosis of the chronic pancreatic diseases. Part 6. Differentiation between chronic pancreatitis and pancreatic cancer.

Authors:  E J Boyd; H Rinderknecht; K G Wormsley
Journal:  Int J Pancreatol       Date:  1988-05

3.  Comparative studies on expression of CA 19-9 and DU-PAN-2 in pancreatic cancer tissue.

Authors:  H Takasaki; E Uchida; M A Tempero; D A Burnett; R S Metzgar; P M Pour
Journal:  Int J Pancreatol       Date:  1987 Oct-Dec

4.  A Multianalyte Panel Consisting of Extracellular Vesicle miRNAs and mRNAs, cfDNA, and CA19-9 Shows Utility for Diagnosis and Staging of Pancreatic Ductal Adenocarcinoma.

Authors:  Zijian Yang; Michael J LaRiviere; Jina Ko; Jacob E Till; Theresa Christensen; Stephanie S Yee; Taylor A Black; Kyle Tien; Andrew Lin; Hanfei Shen; Neha Bhagwat; Daniel Herman; Andrew Adallah; Mark H O'Hara; Charles M Vollmer; Bryson W Katona; Ben Z Stanger; David Issadore; Erica L Carpenter
Journal:  Clin Cancer Res       Date:  2020-04-16       Impact factor: 12.531

5.  p53 protein expression and CA19.9 values in differential cytological diagnosis of pancreatic cancer complicated with chronic pancreatitis and chronic pancreatitis.

Authors:  De-Qing Mu; Guo-Feng Wang; Shu-You Peng
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

Review 6.  Carcinoma of the head of the pancreas versus chronic pancreatitis: diagnostic dilemma with significant consequences.

Authors:  Bryce Taylor
Journal:  World J Surg       Date:  2003-10-13       Impact factor: 3.352

Review 7.  The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates.

Authors:  Katherine E Poruk; D Z Gay; K Brown; J D Mulvihill; K M Boucher; C L Scaife; M A Firpo; S J Mulvihill
Journal:  Curr Mol Med       Date:  2013-03       Impact factor: 2.222

8.  Comparative study on the expression of the blood group antigens Le a, Le b, Le x, Le y and the carbohydrate antigens CA 19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma.

Authors:  J Schwenk; J Makovitzky
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

9.  Tissue expression of the cancer-associated antigens CA 19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma.

Authors:  J Schwenk; J Makovitzky
Journal:  Int J Pancreatol       Date:  1989-07

10.  Factors associated with serum CA19-9 levels among healthy children: a cross-sectional study.

Authors:  Sayo Kawai; Nobuyuki Hamajima; Sueli M Oba-Shinjo; Lucy S Ito; Miyuki Uno; Suely K N Marie
Journal:  BMC Clin Pathol       Date:  2012-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.